GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » Dividend Yield %

Biomark Diagnostics (FRA:20B) Dividend Yield % : 0.00% (As of May. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Dividend Yield %?

As of today (2024-05-27), the Trailing Annual Dividend Yield of Biomark Diagnostics is 0.00%.

The historical rank and industry rank for Biomark Diagnostics's Dividend Yield % or its related term are showing as below:

FRA:20B's Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2
* Ranked among companies with meaningful Dividend Yield % only.

Biomark Diagnostics's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00.

As of today (2024-05-27), the Forward Dividend Yield % of Biomark Diagnostics is 0.00%.

Biomark Diagnostics's Dividends per Share for the three months ended in Dec. 2023 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Biomark Diagnostics Dividend Yield % Historical Data

The historical data trend for Biomark Diagnostics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Dividend Yield % Chart

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biomark Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biomark Diagnostics's Dividend Yield %

For the Diagnostics & Research subindustry, Biomark Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Dividend Yield % falls into.



Biomark Diagnostics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Biomark Diagnostics  (FRA:20B) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Biomark Diagnostics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (FRA:20B) Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines